SCHEMBL23670264

SCHEMBL23670264

C=CCC(C)COS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.40
ALDH1A1 P00352 5/20 0.39
GAA P10253 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
C5AR1 P21730 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
STAT3 P40763 1/20 0.37
TLR9 Q9NR96 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
GBA1 P04062 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
G6PD P11413 1/20 0.35
VDR P11473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23670263 1.00 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL26314799 1.00 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL14978032 0.87 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL2176311 0.85 GAA (0.45) DHODHALDH1A1GAASTAT3TLR9
SCHEMBL32668659 0.84 CA1 (0.39) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL32668754 0.84 CA1 (0.39) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL14953068 0.83 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL14952885 0.83 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL14952884 0.83 DHODH (0.40) DHODHALDH1A1GAAKDM4EMAPT
SCHEMBL15492803 0.81 DHODH (0.39) DHODHALDH1A1GAAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12091425-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2024-09-17 US disclosed
US-20230052348-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2023-02-16 US disclosed
US-11306107-B2 Compounds that inhibit MCL-1 protein AMGEN INC. (US) 2022-04-19 US disclosed
US-20210230189-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2021-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230189-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN MCL1, BCL9, BCL2L1 DHODH 3319/4885ALDH1A1 1891/4885GAA 2465/4885
US-11306107-B2 Compounds that inhibit MCL-1 protein MCL1, BCL9, BCL2L1 DHODH 3319/4885ALDH1A1 1891/4885GAA 2465/4885
US-20230052348-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN MCL1, BCL9, BCL2L1 DHODH 3319/4885ALDH1A1 1891/4885GAA 2465/4885
US-12091425-B2 Compounds that inhibit MCL-1 protein MCL1, BCL9, BCL2L1 DHODH 3319/4885ALDH1A1 1891/4885GAA 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.